Withholding and Withdrawing Life-Sustaining Treatment in Advanced Dementia: How and When to Make These Difficult Decisions
Dementia is a progressive incurable illness. In the advanced stages of the disease, decisions need to be made whether to withhold or withdraw life-sustaining treatment.
Elle a défini des aspects fondamentaux de la qualité de vie des personnes atteintes de démence : ne pas avoir de douleurs ; se sentir en sécurité ; pouvoir participer à des activités intéressantes ; et être à même de conserver le plus haut degré possible d’autonomie.
Fundamental aspects of quality of life for people with dementia: being pain-free; safe; able to participate in meaningful activities; and able to maintain the greatest degree of autonomy possible.
This article highlights the complex challenges seen when managing pain in patients with moderate or advanced dementia.
Dementia-related behavioural problems are common and debilitating. The assessment and management of these problems can be challenging.
Lack of adherence is a major reason for the failure of medical therapies and is an especially important and sometimes underappreciated issue for the growing number of people with dementia.
Practical Approach to the Use of Cholinesterase Inhibitors in Patients with Early Alzheimer’s Disease
Cholinesterase inhibitors are a treatment option for most people with Alzheimer’s disease of mild to moderate severity.
There has been a substantial increase in total cases of diabetes mellitus in industrialized countries among older adults.